Ryuichiro Sato
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ryuichiro Sato has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Tatsuya Takano
Department of Microbiology and Molecular Pathology, Faculty of Pharmaceutical Sciences, Teikyo University
5 shared publications - Tsuneo Imanaka
Department of Biological Chemistry, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-0194, Japan
3 shared publications Jun Inoue
Department of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan
2 shared publicationsKeiji Nakagami
Department of Microbiology and Molecular Pathology, Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Kanagawa 199–01, Japan
2 shared publicationsMasatomo Maeda
Department of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University Suita, Osaka 565-0871
2 shared publications- Masatomo Maeda
Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan
2 shared publications
Latest Publications
- 1 December 2000
- Published by Wiley in European Journal of Biochemistry
- Vol. 267 (23) , 6849-6857
Cloning and bacterial expression of monomeric short-chain dehydrogenase/reductase (carbonyl reductase) from CHO-K1 cells
- 1 December 2000
- Published by Wiley in European Journal of Biochemistry
- Vol. 267 (23) , 6849-6857
Cloning and bacterial expression of monomeric short-chain dehydrogenase/reductase (carbonyl reductase) from CHO-K1 cells
- 1 January 2000
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 25 (5) , 309-315
Insulin-Degrading Enzyme Exists Inside of Rat Liver Peroxisomes and Degrades Oxidized Proteins.
Insulin-degrading enzyme (IDE) was detected by immunoblot analysis in highly purified rat liver peroxisomes. IDE in the peroxisomal fraction was resistant to proteolysis by trypsin and chymotrypsin under conditions where the peroxisomal membranes remained intact. After sonication of the peroxisomal fraction, IDE was recovered in the supernatant fraction. Further, the localization of IDE in the peroxisomes was shown by immunoelectron microscopy. In addition, IDE isolated from peroxisomes degraded insulin as well as oxidized lysozyme as a model substrate for oxidized proteins. These results suggest that IDE exists in an active form in the matrix of rat liver peroxisomes and is involved in elimination of oxidized proteins in peroxisomes.
- 1 January 2000
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 25 (5) , 309-315
Insulin-Degrading Enzyme Exists Inside of Rat Liver Peroxisomes and Degrades Oxidized Proteins.
Insulin-degrading enzyme (IDE) was detected by immunoblot analysis in highly purified rat liver peroxisomes. IDE in the peroxisomal fraction was resistant to proteolysis by trypsin and chymotrypsin under conditions where the peroxisomal membranes remained intact. After sonication of the peroxisomal fraction, IDE was recovered in the supernatant fraction. Further, the localization of IDE in the peroxisomes was shown by immunoelectron microscopy. In addition, IDE isolated from peroxisomes degraded insulin as well as oxidized lysozyme as a model substrate for oxidized proteins. These results suggest that IDE exists in an active form in the matrix of rat liver peroxisomes and is involved in elimination of oxidized proteins in peroxisomes.
- 1 June 1998
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 123 (6) , 1191-1198
Multiple DNA Elements for Sterol Regulatory Element-Binding Protein and NF-Y Are Responsible for Sterol-Regulated Transcription of the Genes for Human 3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase and Squalene Synthase
The expression of the human SREBP-2 gene is transcriptionally regulated in a cooperative manner by sterol regulatory element-binding proteins (SREBPs) and the general transcription factor NF-Y [Sato, R., Inoue, J., Kawabe, Y., Kodama, T., Takano, T., and Maeda, M. (1996) J. Biol. Chem. 271, 26461-26464]. To understand the sterol-dependent transcriptional regulation by these factors in detail, we have examined the regulation of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase and squalene synthase genes, whose promoters have multiple potential sterol regulatory elements (SRE, SREBP binding site) and NF-Y binding sites. The promoter of the human HMG CoA synthase gene was cloned, sequenced, and functionally characterized by means of reporter gene assays. The results indicate that an inverted CCAAT box, two SRE motifs and two Sp1 sites localized in a 90-bp region coordinately regulate the transcription. In the case of the human squalene synthase promoter, two SRE motifs and an inverted CCAAT box between the motifs localized in a 51-bp region are responsible for the sterol-regulated transcription of the gene. Gel mobility shift assay reveals that these two inverted CCAAT boxes are recognized by NF-Y. The involvement of multiple responsive elements in the transcription of HMG CoA synthase and squalene synthase seems to induce a higher level of sterol-dependent regulation (3.5 to 5.8-fold) compared with that of the SREBP-2 promoter, which contains a single pair of SRE motif and CCAAT box (1.8 to 2.6-fold). Reporter gene assays using constructs containing various nucleotide spacing lengths between the SRE motif and the CCAAT box demonstrate that the 16 to 20-bp spacing range is required for maximal transcriptional regulation. These results agree with the findings that the distances between the two motifs in the known sterol responsive elements in several genes, including the human HMG CoA synthase and squalene synthase genes, are in this range.
- 1 June 1998
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 123 (6) , 1191-1198
Multiple DNA Elements for Sterol Regulatory Element-Binding Protein and NF-Y Are Responsible for Sterol-Regulated Transcription of the Genes for Human 3-Hydroxy-3-Methylglutaryl Coenzyme A Synthase and Squalene Synthase
The expression of the human SREBP-2 gene is transcriptionally regulated in a cooperative manner by sterol regulatory element-binding proteins (SREBPs) and the general transcription factor NF-Y [Sato, R., Inoue, J., Kawabe, Y., Kodama, T., Takano, T., and Maeda, M. (1996) J. Biol. Chem. 271, 26461-26464]. To understand the sterol-dependent transcriptional regulation by these factors in detail, we have examined the regulation of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase and squalene synthase genes, whose promoters have multiple potential sterol regulatory elements (SRE, SREBP binding site) and NF-Y binding sites. The promoter of the human HMG CoA synthase gene was cloned, sequenced, and functionally characterized by means of reporter gene assays. The results indicate that an inverted CCAAT box, two SRE motifs and two Sp1 sites localized in a 90-bp region coordinately regulate the transcription. In the case of the human squalene synthase promoter, two SRE motifs and an inverted CCAAT box between the motifs localized in a 51-bp region are responsible for the sterol-regulated transcription of the gene. Gel mobility shift assay reveals that these two inverted CCAAT boxes are recognized by NF-Y. The involvement of multiple responsive elements in the transcription of HMG CoA synthase and squalene synthase seems to induce a higher level of sterol-dependent regulation (3.5 to 5.8-fold) compared with that of the SREBP-2 promoter, which contains a single pair of SRE motif and CCAAT box (1.8 to 2.6-fold). Reporter gene assays using constructs containing various nucleotide spacing lengths between the SRE motif and the CCAAT box demonstrate that the 16 to 20-bp spacing range is required for maximal transcriptional regulation. These results agree with the findings that the distances between the two motifs in the known sterol responsive elements in several genes, including the human HMG CoA synthase and squalene synthase genes, are in this range.
- 1 January 1998
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 23 (6) , 315-323
Structures of P-type Transporting ATPases and Chromosomal Locations of Their Genes.
P-type ATPases (E1E2-ATPases) are primary active transporters which form phospho-intermediates during their catalytic cycle. They are classified into P1 to P4 based on the primary structure and potential transmembrane segments. Although the classic P-type ATPases are cation transporters, two new members have recently been found; one is a flippase catalyzing the flip-flop movement of aminophospholipids, but the substrate and function of the other one remain unknown. It would be interesting to determine whether the cations and aminophospholipids are transported by similar or different mechanisms. P-type ATPases are believed to have been derived from a common ancestor, and their genes are found to be distributed in various chromosomal loci. However, gene duplication events can be traced from the tandem arrangement of genes and their linkage map. Na+/K+- and H+/K+-ATPases have not only closely related a subunits but also similar beta subunits. Renal Na+/K+-ATPase has an additional subunit gamma. Similar small polypeptides (phospholemman, Mat-8 and CHIF), which induce Cl- and K+ currents, have been found. The idea of their functional and structural coupling with P-type ATPases, especially with H+/K+-ATPase, is intriguing. Each P-type ATPase must have specific domains or sequences for its intracellular trafficking (sorting, retention and recycling). Identification of such regions and studies on the molecules playing role in their recognition may facilitate the unveiling of various cellular processes regulated by P-type ATPases.
- 1 January 1998
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 23 (6) , 315-323
Structures of P-type Transporting ATPases and Chromosomal Locations of Their Genes.
P-type ATPases (E1E2-ATPases) are primary active transporters which form phospho-intermediates during their catalytic cycle. They are classified into P1 to P4 based on the primary structure and potential transmembrane segments. Although the classic P-type ATPases are cation transporters, two new members have recently been found; one is a flippase catalyzing the flip-flop movement of aminophospholipids, but the substrate and function of the other one remain unknown. It would be interesting to determine whether the cations and aminophospholipids are transported by similar or different mechanisms. P-type ATPases are believed to have been derived from a common ancestor, and their genes are found to be distributed in various chromosomal loci. However, gene duplication events can be traced from the tandem arrangement of genes and their linkage map. Na+/K+- and H+/K+-ATPases have not only closely related a subunits but also similar beta subunits. Renal Na+/K+-ATPase has an additional subunit gamma. Similar small polypeptides (phospholemman, Mat-8 and CHIF), which induce Cl- and K+ currents, have been found. The idea of their functional and structural coupling with P-type ATPases, especially with H+/K+-ATPase, is intriguing. Each P-type ATPase must have specific domains or sequences for its intracellular trafficking (sorting, retention and recycling). Identification of such regions and studies on the molecules playing role in their recognition may facilitate the unveiling of various cellular processes regulated by P-type ATPases.
- 1 January 1998
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 23 (4) , 187-192
Characterization of Two Chinese Hamster Ovary Cell Lines Expressing the COOH-terminal Domains of Sterol Regulatory Element-binding Protein (SREBP)-1.
Sterol regulatory element-binding proteins (SREBPs) regulate transcription of genes encoding enzymes in the cholesterol biosynthetic pathway and the LDL receptor. These proteins are synthesized as membrane-bound precursors and processed to generate the NH2-terminal domains, mature transcription factors. We established two Chinese hamster ovary (CHO) cell lines, CHO-421 expressing the truncated hamster SREBP-1 (amino acids 421-1133) with two transmenbrane domains and CHO-557 expressing another truncated SREBP-1 (amino acids 557-1133) without any transmembrane domains, to investigate the fate of the COOH terminus after cleavage of the NH2-terminal mature SREBP. The cell fractionation experiments revealed that the two proteins, regardless of the absence of transmembrane domains in the SREBP (557-1133), similarly localized in the nuclear envelope and the microsomal membrane fractions, suggesting that these proteins appear to be tightly bound to a membrane protein(s) localizing on the nuclear and endoplasmic reticulum (ER) membranes. Although we predicted that overexpression of the COOH-terminal domains, which were thought to be involved in the regulation of SREBP processing, would result in disruption of the SREBP-dependent transcriptional regulation of several genes, the mRNA levels for 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase in these two cell lines were regulated in a sterol-dependent manner. Pulse-chase experiments revealed that the SREBP (421-1133) was relatively rapidly degraded (t1/2=4-6 hr) and that the intracellular cholesterol level did not affect the half-life time. The degradation of the SREBP (421-1133) was not suppressed by the treatment of a calpain inhibitor, N-acetyl-leucyl-leucyl-norleucynal (ALLN), which blocks the proteolysis of some proteins within or near the ER. In CHO-557 cells the SREBP (557-1133) was much more rapidly degraded (t1/2=1-2 hr), suggesting that the cytosolic COOH-terminal domain is accessible to the enzymatic attacks from the cytoplasm. Taken together, overexpression of the COOH-terminal domains does not affect the regulation of SREBP processing and the domains are rapidly turned over by the cytosolic proteolytic process distinct from the ALLN-sensitive ER degradative pathway.
- 1 January 1998
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 23 (4) , 187-192
Characterization of Two Chinese Hamster Ovary Cell Lines Expressing the COOH-terminal Domains of Sterol Regulatory Element-binding Protein (SREBP)-1.
Sterol regulatory element-binding proteins (SREBPs) regulate transcription of genes encoding enzymes in the cholesterol biosynthetic pathway and the LDL receptor. These proteins are synthesized as membrane-bound precursors and processed to generate the NH2-terminal domains, mature transcription factors. We established two Chinese hamster ovary (CHO) cell lines, CHO-421 expressing the truncated hamster SREBP-1 (amino acids 421-1133) with two transmenbrane domains and CHO-557 expressing another truncated SREBP-1 (amino acids 557-1133) without any transmembrane domains, to investigate the fate of the COOH terminus after cleavage of the NH2-terminal mature SREBP. The cell fractionation experiments revealed that the two proteins, regardless of the absence of transmembrane domains in the SREBP (557-1133), similarly localized in the nuclear envelope and the microsomal membrane fractions, suggesting that these proteins appear to be tightly bound to a membrane protein(s) localizing on the nuclear and endoplasmic reticulum (ER) membranes. Although we predicted that overexpression of the COOH-terminal domains, which were thought to be involved in the regulation of SREBP processing, would result in disruption of the SREBP-dependent transcriptional regulation of several genes, the mRNA levels for 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase in these two cell lines were regulated in a sterol-dependent manner. Pulse-chase experiments revealed that the SREBP (421-1133) was relatively rapidly degraded (t1/2=4-6 hr) and that the intracellular cholesterol level did not affect the half-life time. The degradation of the SREBP (421-1133) was not suppressed by the treatment of a calpain inhibitor, N-acetyl-leucyl-leucyl-norleucynal (ALLN), which blocks the proteolysis of some proteins within or near the ER. In CHO-557 cells the SREBP (557-1133) was much more rapidly degraded (t1/2=1-2 hr), suggesting that the cytosolic COOH-terminal domain is accessible to the enzymatic attacks from the cytoplasm. Taken together, overexpression of the COOH-terminal domains does not affect the regulation of SREBP processing and the domains are rapidly turned over by the cytosolic proteolytic process distinct from the ALLN-sensitive ER degradative pathway.
- Open Access
- 1 October 1996
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (43) , 26461-26464
Sterol-dependent Transcriptional Regulation of Sterol Regulatory Element-binding Protein-2
- 1 October 1996
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 271 (43) , 26461-26464
Open AccessSterol-dependent Transcriptional Regulation of Sterol Regulatory Element-binding Protein-2
- 1 January 1994
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 1 (Supplemmen) , S50-S54
Accumulation of Vitronectin in Atherosclerotic Lesions where Lipids Deposited
- 1 January 1994
- Published by Japan Atherosclerosis Society in Journal of Atherosclerosis and Thrombosis
- Vol. 1 (Supplemmen) , S50-S54
Accumulation of Vitronectin in Atherosclerotic Lesions where Lipids Deposited
- 1 August 1990
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 598 (1) , 517-519
Monoclonal Antibody EMR1a/212D Recognizing the Extracellular Matrix in Atherosclerosis.
- 1 August 1990
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 598 (1) , 517-519
Monoclonal Antibody EMR1a/212D Recognizing the Extracellular Matrix in Atherosclerosis.
- 1 January 1988
- Published by Japan Atherosclerosis Society in The Journal of Japan Atherosclerosis Society
- Vol. 16 (7) , 939-941
Monoclonal Antibody (EMR1a/212D) Recognizing Extracellular Regions with Lipid-deposits: Purification and Characterization of the Antigenic Material
Antigenic material recognized by monoclonal antibody EMR1a/212D against extracellular matrix deposited with lipid was purified from serum of WHHL rabbits. The antigenic material was purified in a single band by SDS-PAGE followed by DEAF-Sepharose CL-6B column, EMR1a/212D coupled immunoaffinity column, and HPLC equipped with TSK gel G3000SWXL, column chromatography. The purified antigenic material was a glycoprotein with a molecular weight of 66k daltons. The amino acid residue of the antigenic material was remarkably high in glutamic acid and aspartic acid. However, the residue was low in arginine and lysine. Its isoelectric point was at pH 5.4-5.9. The antigenic material contained 22.2mg sugar per 100mg protein, and at least sialic acid expressed the activity of the epitope, because antigenic activity was decreased by neuraminidase treatment.
- 1 January 1988
- Published by Japan Atherosclerosis Society in The Journal of Japan Atherosclerosis Society
- Vol. 16 (7) , 939-941
Monoclonal Antibody (EMR1a/212D) Recognizing Extracellular Regions with Lipid-deposits: Purification and Characterization of the Antigenic Material
Antigenic material recognized by monoclonal antibody EMR1a/212D against extracellular matrix deposited with lipid was purified from serum of WHHL rabbits. The antigenic material was purified in a single band by SDS-PAGE followed by DEAF-Sepharose CL-6B column, EMR1a/212D coupled immunoaffinity column, and HPLC equipped with TSK gel G3000SWXL, column chromatography. The purified antigenic material was a glycoprotein with a molecular weight of 66k daltons. The amino acid residue of the antigenic material was remarkably high in glutamic acid and aspartic acid. However, the residue was low in arginine and lysine. Its isoelectric point was at pH 5.4-5.9. The antigenic material contained 22.2mg sugar per 100mg protein, and at least sialic acid expressed the activity of the epitope, because antigenic activity was decreased by neuraminidase treatment.